CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. IBM
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. TSLA

Go back to CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
(NASDAQ: QNRX) Delayed: 4.80 +0.39 (8.84%)
Previous Close $4.41    52 Week High $ 
Open $4.20    52 Week Low $ 
Day High $4.80    P/E N/A 
Day Low $4.10    EPS $ 
Volume 544,643